Here are six key notes:
1. There weren’t any terms given for the filing. However, the offering is valued up to $75 million.
2. Ellipse Technologies plans to file on the Nasdaq Global Market with the symbol MGEC. The company’s technology, MAGnetic External Control, or MAGEC, is used to adjust growing rods in young patients who need surgical correction.
3. Piper Jaffray, Canaccord Genuity, William Blair and Oppenheimer are underwriters for the IPO.
4. There is a global addressable market for Ellipse’s commercial products at $1.2 billion in 2014.
5. Ellipse reported net revenue at $12 million in 2013 and $25 million in 2014; net losses were at $5.3 million in 2013 and $3.2 million in 2014.
6. The company expects to continue incurring net losses over the next few years, and as of Sept. 30, the accumulated deficit was $41.8 million, according to the report.
More articles on orthopedic devices:
Globus Medical introduces new MIS pedicle screw system: 5 points
5 key notes on the European spine devices market
Zimmer Biomet tackles Q3 after merger; sales up 59%: 10 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
